In the BioHarmony Drug Report Database

"Preview" Icon

Enalaprilat

Vasotec (enalaprilat) is a small molecule pharmaceutical. Enalaprilat was first approved as Vasotec on 1988-02-09. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme.

 

Trade Name

 

Vasotec
 

Common Name

 

enalaprilat
 

ChEMBL ID

 

CHEMBL577
 

Indication

 

bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, rheumatoid arthritis
 

Drug Class

 

Narcotic agonists/antagonists (normorphine type); antihypertensives (ACE inhibitors): diacid analogs

Image (chem structure or protein)

Enalaprilat structure rendering